PDCD1 and cancer: Additionally, PD-1 inhibitors can promote the formation of memory T cells and enhance the immune system’s sustained ability to attack cancer cells (Khasraw et al., 2020; Liu J. et al., 2021; Yang Z. et al., 2022) (Figure 1).